Dental Implant, Implant Stability
Conditions
Keywords
Bone level, tissue level, osseointegration, biomechanical analysis, implant design, Insertion torque
Brief summary
It is a prospective clinical study to compare two implants of the same brand of a similar design for implantation \[either at the bone tissue level or at the soft tissue level\], in order to evaluate the marginal bone loss of each dental implant in mm. 96 patients will be analyzed (an expected N of 48 per group, hoping to reach 100 implants per arm).
Detailed description
it is a study to evualte the marginal bone loss in bone level and tissue level dental implants
Interventions
Surgical placement of Bone-level and Tissue-level dental implants.
Sponsors
Study design
Intervention model description
placement of dental implants in bone level and tissue level
Eligibility
Inclusion criteria
* Patients of both sexes, over 18 years of age, who need dental implant placement for prosthetic rehabilitation. Whether partially or completely in both the maxilla and the mandible. * Patients with residual alveolar ridge with at least 8 mm of bone height and 4 mm of width. * Patients must have the ability to understand and decide when voluntarily signing the informed consent before carrying out any intervention related to the study. * Patients who, after being informed about the objectives and procedures of the research, agree will sign the informed consent form. And they are ready to carry out the different study visits.
Exclusion criteria
* Patients with uncontrolled systemic diseases (ASA ≥ III). * Patients who do not have 8mm bone height and/or 4mm width * Patients who require bone regeneration * Patients with severe periodontal disease or acute pericoronitis. * Pregnant and breastfeeding women. * Patients with Deficient or Inadequate Oral Hygiene. * Patients with severe bruxism. * Patients taking bisphosphonates or other antiresority medications. * Smoker of more than 10 cigarettes/day. * Patients with uncontrolled diabetes mellitus. * Psychiatric illnesses or unrealistic expectations. * Immunodepressed or immunocompromised patient.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| marginal bone loss | 6 months | mm |
| Torque | up to 24 weeks | N·cm |
Countries
Spain